Latest From Laborie
Medtech Insight recorded 17 merger or acquisition deals in March, a rise from the nine deals recorded last month and in the same period last year. It was a busy month for Boston Scientific, which racked up two acquisitions, paying $460m for urology device maker NxThera and an undisclosed price for endoscopy firm EMcision.
The deal adds Cogentix' Urgent PC neuromodulation system for urinary incontinence, PrimeSight cystoscopy system, and Macroplastique soft-tissue bulking agent to treat female stress urinary incontinence to Laborie's range of urology and gynecology products.
M&A deal activity waned in March, with a total of 9 deals completed in the month, down from 12 in February and 17 in March 2016. This third month brought the total number of deals for Q1 2017 to 33, a significant year-on-year decline compared to 51 in the first quarter of 2016.
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bi-monthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. This month we highlight deals announced in January and February 2017.
- Consumables, Central Supplies
- Diagnostic Equipment & Supplies
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Monitoring Equipment & Devices
- Rehabilitation Equipment and Devices
- Therapeutic Areas
- Gynecological, Urological
- Laborie Medical Technologies Inc.
- North America
- Parent & Subsidiaries
- Senior Management
Michael Frazzette, Pres. & CEO
Walter Stothers, CFO
Ian McLean, VP, Global Mktg.
Robert Mueller, VP, Global Operations
- Contact Info
Phone: (905) 612-1170
6415 Northwest Dr.
Mississauga, L4V 1X1
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.